0001553878-13-000001.txt : 20130212
0001553878-13-000001.hdr.sgml : 20130212
20130212174456
ACCESSION NUMBER: 0001553878-13-000001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130208
FILED AS OF DATE: 20130212
DATE AS OF CHANGE: 20130212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Reid Laurence
CENTRAL INDEX KEY: 0001492749
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50743
FILM NUMBER: 13598582
MAIL ADDRESS:
STREET 1: 300 THIRD STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALNYLAM PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001178670
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770602661
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 THIRD STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: (617) 551-8200
MAIL ADDRESS:
STREET 1: 300 THIRD STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: ALNYLAM PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20020724
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2013-02-08
0
0001178670
ALNYLAM PHARMACEUTICALS, INC.
ALNY
0001492749
Reid Laurence
300 THIRD STREET
CAMBRIDGE
MA
02142
0
1
0
0
SVP, Chief Business Officer
Common Stock
2013-02-08
4
M
0
5000
7.1
A
16681
D
Common Stock
2013-02-08
4
S
0
5000
25
D
11681
D
Common Stock
1507
I
By Managed Account
Stock Option (Right to Buy)
7.1
2013-02-08
4
M
0
5000
0
D
2021-11-30
Common Stock
5000
35000
D
The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2012.
The reporting person owns 1,507 shares of ALNY common stock under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.
/s/ Michael P. Mason, as Attorney-in-Fact for Laurence Reid
2013-02-12